SEC Form 5 · accession 0001140361-15-003955
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 4, 2015 · 11:13 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 31, 2014 | G | 1,000 | $0.00 | D | 226,157 | D | |
| Common StockF1 | Oct 29, 2014 | G | 7,011 | $0.00 | D | 36,184 | I | Shares held by Bienaime Family Trust |
| Common StockF1 | Oct 29, 2014 | G | 7,011 | $0.00 | A | 233,168 | D | |
| Common Stock | Nov 13, 2014 | G | 2,400 | $0.00 | D | 230,768 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On October 29, 2014 the reporting person transferred 7,011 shares of common stock from his family trust to his personal account. The reporting person and his spouse are trustees.